Logotype for Doxee S.p.A.

Doxee (DOX) H1 2025 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Doxee S.p.A.

H1 2025 earnings summary

30 Sep, 2025

Executive summary

  • Achieved 21% year-over-year revenue growth in H1 2025 to €15.1 million, driven by strong performance in Italy (+9%) and the DACH region (+73%), with strategic client wins.

  • Returned to profitability with net income of €0.04 million, compared to a loss of €2.4 million in H1 2024.

  • EBITDA rose sharply to €2.9 million from €0.5 million in H1 2024, reflecting efficiency gains and cost containment.

  • Net financial debt reduced to €15.5 million from €19.3 million at FY 2024, supported by positive cash flow.

  • Organizational integration and technology improvements under the ONE Company and ONE Platform initiatives enhanced efficiency and value proposition.

Financial highlights

  • Revenues reached €15.1 million (+21% YoY); gross margin rose to €10.3 million (+37% YoY).

  • Value of production increased 16% to €16.2 million compared to H1 2024.

  • Recurring subscription revenues were €10.9 million, up 17.1% and representing over 73% of turnover.

  • Professional services revenue grew 17.2% to €4.2 million.

  • Cash flow from operations was €5.0 million, up from €1.5 million in H1 2024.

Outlook and guidance

  • Focus on sustainable revenue growth, operational leverage, and high ROI per unit investment.

  • Management expects continued growth and profitability in H2 2025, focusing on organic growth, platform integration, and AI development.

  • Investments planned in sales through partners, AI agents, and proprietary LLM foundation.

  • Ongoing reduction of net financial debt is targeted without renegotiation with banks.

  • Continued expansion in DACH and CEE regions, with a strong commercial pipeline and low churn rate.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more